Search - tctmd.com

Displaying 1 - 20 of 202

Sort: Relevancy | Date

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

Shelley Wood

November 28, 2023

News Conference News PCR London Valves 2023

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

Shelley Wood

November 20, 2023

News Conference News PCR London Valves 2023

Acute Decompensated Aortic Stenosis: Time for an Urgent TAVI Pathway?

Shelley Wood

November 20, 2023

News Daily News

Ross Procedure Offers ‘Excellent Survival’ 25 Years Out

Caitlin E. Cox

November 15, 2023

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

News Conference News TCT 2023

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

Todd Neale

October 26, 2023

News Conference News TCT 2023

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Yael L. Maxwell

October 26, 2023

Presentation TCT 2023

Patient Reported Outcomes in TTVI: Are They Meaningful?

Presenter: David Cohen

October 26, 2023

Presentation TCT 2023

TAVR for AR: next steps and future challenges

Presenter: Duane Pinto

October 26, 2023

Presentation TCT 2023

Review of the Current Clinical Evidence for Transcatheter Tricuspid Valve Therapies

Presenter: Susheel Kodali

October 26, 2023

Presentation TCT 2023

The Trilogy TAVR System and the ALIGN-AR Study

Presenter: Raj Makkar

October 26, 2023

Presentation TCT 2023

Current Guideline-Directed Medical Management: Will We Ever Have Class I Management Options?

Presenter: JoAnn Lindenfeld

October 26, 2023

Presentation TCT 2023

From diagnosis to treatment: the progression of disease and why we consistently undertreat AR

Presenter: Philippe Genereux

October 26, 2023

Presentation TCT 2023

Just how big is the AR problem? Understanding the underestimation and underdiagnosis of AR

Presenter: Saif Anwaruddin

October 26, 2023

Presentation TCT 2023

What We Now Know About Tricuspid Regurgitation Outcomes: Differences in Natural History Based on Etiology

Presenter: Rebecca Hahn

October 26, 2023

Presentation TCT 2023

TCT 392: Prognostic impact of vasopressor test during edge-to-edge repair of secondary mitral regurgitation

Presenter: Jose Carlos Gonzalez Gutiérrez

October 26, 2023

Advertisement

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

Acute Decompensated Aortic Stenosis: Time for an Urgent TAVI Pathway?

Ross Procedure Offers ‘Excellent Survival’ 25 Years Out

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Patient Reported Outcomes in TTVI: Are They Meaningful?

TAVR for AR: next steps and future challenges

Review of the Current Clinical Evidence for Transcatheter Tricuspid Valve Therapies

The Trilogy TAVR System and the ALIGN-AR Study

Current Guideline-Directed Medical Management: Will We Ever Have Class I Management Options?

From diagnosis to treatment: the progression of disease and why we consistently undertreat AR

Just how big is the AR problem? Understanding the underestimation and underdiagnosis of AR

What We Now Know About Tricuspid Regurgitation Outcomes: Differences in Natural History Based on Etiology

TCT 392: Prognostic impact of vasopressor test during edge-to-edge repair of secondary mitral regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content